Skip to content

Pharminent

cropped-ChatGPT-Image-May-28-2026-10_46_23-PM.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Manufacturing
  • USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns
  • Manufacturing

USP adds Tamiflu, Trulicity to vulnerable list as upstream analysis reshapes supply concerns

BioSpace

Almost half of the top 100 medicines vulnerable to supply disruptions in the U.S.

ManufacturingRead full story

pharminent April 13, 2026 (Last updated: April 13, 2026)

BioSpace

Almost half of the top 100 medicines vulnerable to supply disruptions in the U.S.

ManufacturingRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Allogene stock sails after CAR T clears residual lymphoma in early data cut
Next: FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results

Related Stories

  • Manufacturing

FUJIFILM opens new iPSC facility in Madison, US

pharminent May 21, 2026
  • Manufacturing

Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities

pharminent May 12, 2026
  • Manufacturing

Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing

pharminent May 7, 2026

You May Have Missed

  • Policy / Pricing

Eli Lilly issues data sharing ultimatum to 340B hospitals

pharminent June 2, 2026
  • M&A / Deals

Fulcrum exploring a potential sale after FDA sidelined its sickle cell drug

pharminent June 2, 2026
  • Clinical Data

ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma

pharminent June 2, 2026
  • Clinical Data

ASCO26: In vivo oncology approaches continue to show promise

pharminent June 2, 2026
Copyright © 2026 All rights reserved. | ReviewNews by AF themes.